{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:22:05Z","timestamp":1789604525892,"version":"build-2803163510"},"reference-count":334,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204295"],"award-info":[{"award-number":["82204295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["825B2116"],"award-info":[{"award-number":["825B2116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373805"],"award-info":[{"award-number":["82373805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373809"],"award-info":[{"award-number":["82373809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.apsb.2026.01.013","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:47:16Z","timestamp":1768549636000},"page":"2794-2837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advances in immune cell-based therapeutic agents for the treatment of inflammation-related diseases"],"prefix":"10.1016","volume":"16","author":[{"given":"Yuxin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9097-9587","authenticated-orcid":false,"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.01.013_bib1","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/antiox11010029","article-title":"Punicalagin regulates signaling pathways in inflammation-associated chronic diseases","volume":"11","author":"Xu","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.apsb.2026.01.013_bib3","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/ijms22052605","article-title":"New perspectives in the study of intestinal inflammation: focus on the resolution of inflammation","volume":"22","author":"Camba-Gomez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2019.03.007","article-title":"Cytokine circuits in cardiovascular disease","volume":"50","author":"Williams","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","article-title":"Immune signaling in neurodegeneration","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12931-021-01792-y","article-title":"Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development","volume":"22","author":"Yang","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41578-022-00426-z","article-title":"Design of therapeutic biomaterials to control inflammation","volume":"7","author":"Tu","year":"2022","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib9","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2026.01.013_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-022-01540-7","article-title":"Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression","volume":"41","author":"Gravina","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.592242","article-title":"Cryopreservation as a key element in the successful delivery of cell-based therapies\u2014a review","volume":"7","author":"Meneghel","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib12","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110298","article-title":"Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: a review","volume":"106","author":"He","year":"2020","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.apsb.2026.01.013_bib14","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/acsnano.7b09041","article-title":"Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination","volume":"12","author":"Yang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12645-023-00217-3","article-title":"Emerging applications of extracellular vesicles in tumor therapy","volume":"14","author":"Luo","year":"2023","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","article-title":"Extracellular vesicles as drug delivery systems: why and how?.","volume":"159","author":"Elsharkasy","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.01.013_bib17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"Netea","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib18","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase \u2162 trial","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.013_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41590-021-01047-4","article-title":"Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity","volume":"22","author":"Di","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib21","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.immuni.2025.09.012","article-title":"Inflammation in atherosclerosis: lessons and therapeutic implications","volume":"58","author":"Libby","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41467-023-36614-w","article-title":"GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis","volume":"14","author":"Wei","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib24","first-page":"520","article-title":"Macrophage polarization: an important role in inflammatory diseases","volume":"15","author":"Luo","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib25","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41586-024-08022-7","article-title":"Gasdermin D-mediated metabolic crosstalk promotes tissue repair","volume":"634","author":"Chi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.013_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib27","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/procel\/pwae045","article-title":"Lcn2 secreted by macrophages through NLRP3 signaling pathway induced severe pneumonia","volume":"16","author":"Liu","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2026.01.013_bib29","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib30","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1039\/D1NR06518A","article-title":"Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer","volume":"14","author":"Wang","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2026.01.013_bib31","article-title":"Macrophage-mediated cancer drug delivery","volume":"11\u201312","author":"Wang","year":"2021","journal-title":"Mater Today Sustain"},{"key":"10.1016\/j.apsb.2026.01.013_bib32","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.abc0269","article-title":"NF-kappaB dynamics determine the stimulus specificity of epigenomic reprogramming in macrophages","volume":"372","author":"Cheng","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.01.013_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/ar300","article-title":"NF-kappaB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction","volume":"3","author":"Makarov","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib35","article-title":"Occurrences and functions of Ly6Chi and Ly6Clo macrophages in health and disease","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib36","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Stiffness sensing via piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis","volume":"10","author":"Wang","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado1227","article-title":"Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury","volume":"9","author":"Ruscitti","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ni.2921","article-title":"Neutrophils at work","volume":"15","author":"Nauseef","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","article-title":"The neutrophil","volume":"54","author":"Burn","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.01.013_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41392-024-02049-y","article-title":"Neutrophil diversity and function in health and disease","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib42","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.2147\/IJN.S328705","article-title":"The advances of neutrophil-derived effective drug delivery systems: a key review of managing tumors and inflammation","volume":"16","author":"Wang","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.01.013_bib43","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1021\/acsnano.2c11764","article-title":"Sensitizing tumors to immune checkpoint blockage via sting agonists delivered by tumor-penetrating neutrophil cytopharmaceuticals","volume":"17","author":"Hao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib44","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","article-title":"Neutrophil plasticity in the tumor microenvironment","volume":"133","author":"Giese","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.01.013_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.01.013_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1075260","article-title":"No NETs no TIME: crosstalk between neutrophil extracellular traps and the tumor immune microenvironment","volume":"13","author":"Fang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib48","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/cvr\/cvab329","article-title":"Neutrophil extracellular traps: from physiology to pathology","volume":"118","author":"Hidalgo","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib50","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41586-024-07820-3","article-title":"Recognition and control of neutrophil extracellular trap formation by MICL","volume":"633","author":"Malamud","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.013_bib51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702726","article-title":"Regulatory T cells: barriers of immune infiltration into the tumor microenvironment","volume":"12","author":"Scott","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib53","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037929","article-title":"Memory T-cell heterogeneity and terminology","volume":"13","author":"Muroyama","year":"2021","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.apsb.2026.01.013_bib54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.01.013_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf0095","article-title":"Early-life imprinting of unconventional T cells and tissue homeostasis","volume":"374","author":"Constantinides","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.01.013_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41577-021-00557-4","article-title":"The role of T cells in age-related diseases","volume":"22","author":"Carrasco","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib57","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.013_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.890894","article-title":"iPSCs in NK cell manufacturing and NKEV development","volume":"13","author":"Boyd-Gibbins","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib59","article-title":"Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases","volume":"14","author":"He","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.732135","article-title":"Current perspectives on \"off-the-shelf\" allogeneic NK and CAR-NK cell therapies","volume":"12","author":"Heipertz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib61","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue determinants of human NK cell development, function, and residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.01.013_bib62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12026-015-8664-y","article-title":"Practical NK cell phenotyping and variability in healthy adults","volume":"62","author":"Angelo","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib63","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-101819-074948","article-title":"Natural killer cells: from innate to adaptive features","volume":"39","author":"Mujal","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.immuni.2008.08.001","article-title":"Dendritic cells in vivo: a key target for a new vaccine science","volume":"29","author":"Steinman","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib65","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib66","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","article-title":"SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity","volume":"620","author":"Guo","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.013_bib67","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1182\/blood-2011-01-330530","article-title":"A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice","volume":"118","author":"Hao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.01.013_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ncprheum0042","article-title":"B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus","volume":"2","author":"Eisenberg","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.apsb.2026.01.013_bib69","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","article-title":"CAR T-cell therapy in autoimmune diseases","volume":"402","author":"Schett","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.013_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"Van Delft","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.apsb.2026.01.013_bib71","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.01.013_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.01.013_bib73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib74","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.01.013_bib75","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.01.013_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.933847","article-title":"Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation","volume":"13","author":"Van Geffen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00054","article-title":"Mast cells in stress, pain, blood\u2012brain barrier, neuroinflammation and Alzheimer's disease","volume":"13","author":"Kempuraj","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2026.01.013_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2015.07.017","article-title":"Non-IgE mediated mast cell activation","volume":"778","author":"Yu","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2026.01.013_bib80","article-title":"Mast cells: a double-edged sword in inflammation and fibrosis","volume":"12","author":"Wang","year":"2024","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2026.01.013_bib81","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.immuni.2020.12.017","article-title":"Directional mast cell degranulation of tumor necrosis factor into blood vessels primes neutrophil extravasation","volume":"54","author":"Dudeck","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib82","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41565-023-01584-z","article-title":"Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy","volume":"19","author":"Du","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41467-023-44304-w","article-title":"Synovial microenvironment-influenced mast cells promote the progression of rheumatoid arthritis","volume":"15","author":"Lei","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib84","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.immuni.2018.09.023","article-title":"Adult connective tissue-resident mast cells originate from late erythro-myeloid progenitors","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib85","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1158\/0008-5472.CAN-21-3424","article-title":"Few, but efficient: the role of mast cells in breast cancer and other solid tumors","volume":"82","author":"Majorini","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib86","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s44222-024-00214-0","article-title":"Designing drug delivery systems for cell therapy","volume":"2","author":"Wang","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.apsb.2026.01.013_bib87","first-page":"449","article-title":"Macrophage membrane-biomimetic adhesive polycaprolactone nanocamptothecin for improving cancer-targeting efficiency and impairing metastasis","volume":"20","author":"Ying","year":"2023","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib88","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1039\/C8SC00015H","article-title":"Macrophage-mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control","volume":"9","author":"Evans","year":"2018","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib89","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1021\/acsami.9b23632","article-title":"Macrophage-mediated delivery of multifunctional nanotherapeutics for synergistic chemo-photothermal therapy of solid tumors","volume":"12","author":"Nguyen","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.01.013_bib90","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1021\/acsnano.3c02013","article-title":"Neutrophil-mediated delivery of nanocrystal drugs via photoinduced inflammation enhances cancer therapy","volume":"17","author":"Su","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303211","article-title":"Macrophage membrane-modified MoS2 quantum dots as a nanodrug for combined multi-targeting of Alzheimer's disease","volume":"13","author":"Qi","year":"2024","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biomaterials.2018.07.035","article-title":"Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma","volume":"181","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.01.013_bib93","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1039\/D2NR02012B","article-title":"In situ release of IL-2\/IL-12 from SiO2-engineered dendritic cells for synergistic immunotherapy","volume":"14","author":"Xu","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2026.01.013_bib94","article-title":"Neutrophil camouflaged stealth nanovehicle for photothermal-induced tumor immunotherapy by triggering pyroptosis","volume":"10","author":"Yu","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib95","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0076-6879(87)49059-9","article-title":"Hypotonic hemolysis methods for entrapment of agents in resealed erythrocytes","volume":"149","author":"Ihler","year":"1987","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.apsb.2026.01.013_bib96","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/acs.accounts.7b00526","article-title":"Leveraging engineering of cells for drug delivery","volume":"51","author":"Chen","year":"2018","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib97","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1039\/C7TB00038C","article-title":"Electroporation for nanomedicine: a review","volume":"5","author":"Kim","year":"2017","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2026.01.013_bib98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","article-title":"Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation","volume":"4","author":"Yang","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.01.013_bib99","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s40820-020-00531-0","article-title":"Nanoparticle-loaded polarized-macrophages for enhanced tumor targeting and cell-chemotherapy","volume":"13","author":"Hou","year":"2020","journal-title":"Nano-Micro Lett"},{"key":"10.1016\/j.apsb.2026.01.013_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113841","article-title":"Neutrophil mediated drug delivery for targeted glioblastoma therapy: a comprehensive review","volume":"156","author":"Hosseinalizadeh","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.01.013_bib101","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief update on endocytosis of nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.01.013_bib102","article-title":"Progress in tumor-associated macrophages: from bench to bedside","volume":"3","author":"Wang","year":"2018","journal-title":"Adv Biosyst"},{"key":"10.1016\/j.apsb.2026.01.013_bib103","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1039\/C9SC06497D","article-title":"Surface chemistry of gold nanoparticles for health-related applications","volume":"11","author":"Zhang","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib104","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1039\/C8EN00521D","article-title":"The role of nanoparticle shape in translocation across the pulmonary surfactant layer revealed by molecular dynamics simulations","volume":"5","author":"Luo","year":"2018","journal-title":"Environ Sci Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib105","article-title":"Voluntary-opsonization-enabled precision nanomedicines for inflammation treatment","volume":"33","author":"Li","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib106","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1158\/1535-7163.MCT-20-0167","article-title":"Cabozantinib unlocks efficient in vivo targeted delivery of neutrophil-loaded nanoparticles into murine prostate tumors","volume":"20","author":"Chaudagar","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib107","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2020.11.039","article-title":"A \"dual-guide\" bioinspired drug delivery strategy of a macrophage-based carrier against postoperative triple-negative breast cancer recurrence","volume":"329","author":"Qiu","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.01.013_bib108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41565-021-00997-y","article-title":"Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation","volume":"17","author":"Myerson","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805557","article-title":"Nanoparticle-laden macrophages for tumor-tropic drug delivery","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.apsb.2017.12.001","article-title":"Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy","volume":"8","author":"Huang","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.01.013_bib111","article-title":"Real-time imaging tracking of engineered macrophages as ultrasound-triggered cell bombs for cancer treatment","volume":"30","author":"Xu","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2021.11.016","article-title":"Nano-engineered immune cells as \"guided missiles\" for cancer therapy","volume":"341","author":"Zhang","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.01.013_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002200","article-title":"Engineered microglia potentiate the action of drugs against glioma through extracellular vesicles and tunneling nanotubes","volume":"10","author":"Du","year":"2021","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib114","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib115","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.apsb.2024.08.033","article-title":"Localized light-triggered release macrophage cytopharmaceuticals containing O-nitrobenzyl group for enhanced solid tumor cell-chemotherapy","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.01.013_bib116","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.1038\/s41467-024-52500-5","article-title":"Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib117","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcyt.2020.01.003","article-title":"A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cells","volume":"22","author":"Frank","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.apsb.2026.01.013_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101280","article-title":"Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes","volume":"40","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2026.01.013_bib119","article-title":"Click-chemistry-mediated cell membrane glycopolymer engineering to potentiate dendritic cell vaccines","volume":"63","author":"Yang","year":"2023","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2026.01.013_bib120","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1039\/D1MH01813B","article-title":"Enhanced antibacterial function of a supramolecular artificial receptor-modified macrophage (SAR-macrophage)","volume":"9","author":"Cheng","year":"2022","journal-title":"Mater Horiz"},{"key":"10.1016\/j.apsb.2026.01.013_bib121","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1021\/acsnano.2c08834","article-title":"Spatial-drug-laden protease-activatable M1 macrophage system targets lung metastasis and potentiates antitumor immunity","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114840","article-title":"Engineering cells for precision drug delivery: new advances, clinical translation, and emerging strategies","volume":"197","author":"Chao","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.01.013_bib123","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1021\/acsnano.1c08538","article-title":"Enzyme catalysis biomotor engineering of neutrophils for nanodrug delivery and cell-based thrombolytic therapy","volume":"16","author":"Zheng","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6579","article-title":"Cellular backpacks for macrophage immunotherapy","volume":"6","author":"Shields","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41551-024-01180-z","article-title":"Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy","volume":"8","author":"Kumbhojkar","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.01.013_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202202603","article-title":"In situ activated NK cell as bio-orthogonal targeted live-cell nanocarrier augmented solid tumor immunotherapy","volume":"32","author":"Meng","year":"2022","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib127","doi-asserted-by":"crossref","first-page":"126","DOI":"10.30574\/gscbps.2022.20.1.0283","article-title":"Cellular backpacks for macrophage immunotherapy\u2014a review","volume":"20","author":"Rama","year":"2022","journal-title":"GSC Biol Pharm Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib128","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1007\/s40843-024-3139-3","article-title":"Tannic acid-based metal\u2013phenolic networks as a versatile platform to mediate cell therapy","volume":"67","author":"Luo","year":"2024","journal-title":"Sci China Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib129","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41467-020-14963-0","article-title":"Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102096","article-title":"Targeting neutrophils potentiates hitchhiking delivery of drugs and agonists for postsurgical chemo-immunotherapy","volume":"54","author":"Gao","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2026.01.013_bib131","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1021\/acsnano.3c01428","article-title":"Nanoparticles hitchhike on monocytes for glioblastoma treatment after low-dose radiotherapy","volume":"17","author":"Kuang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib132","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/jacs.9b11046","article-title":"In vivo monocyte\/macrophage-hitchhiked intratumoral accumulation of nanomedicines for enhanced tumor therapy","volume":"142","author":"Zheng","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2026.01.013_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202301779","article-title":"Bacteria-derived outer-membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy","volume":"35","author":"Pan","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib134","first-page":"1528","article-title":"Cell relay-delivery improves targeting and therapeutic efficacy in tumors","volume":"6","author":"Feng","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12951-021-00926-0","article-title":"Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19","volume":"19","author":"Tan","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib136","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib137","first-page":"529","article-title":"Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice","volume":"6","author":"Han","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib138","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1016\/j.matt.2021.08.015","article-title":"Biomimetic immunomodulation by crosstalk with nanoparticulate regulatory T cells","volume":"4","author":"Li","year":"2021","journal-title":"Matter"},{"key":"10.1016\/j.apsb.2026.01.013_bib139","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.2147\/IJN.S415139","article-title":"Multi-site attack, neutrophil membrane-camouflaged nanomedicine with high drug loading for enhanced cancer therapy and metastasis inhibition","volume":"18","author":"Huang","year":"2023","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.01.013_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1122585","article-title":"Opportunities and challenges of natural killer cell-derived extracellular vesicles","volume":"11","author":"Qi","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100047","article-title":"Encapsulation of hydrophilic compounds in small extracellular vesicles: loading capacity and impact on vesicle functions","volume":"11","author":"Hettich","year":"2022","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib142","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.semcancer.2021.02.010","article-title":"New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies","volume":"74","author":"Jayasinghe","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2026.01.013_bib143","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/mt.2016.126","article-title":"Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing","volume":"24","author":"Didiot","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib144","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11481-019-09884-9","article-title":"Macrophage-derived extracellular vesicles as drug delivery systems for triple negative breast cancer (TNBC) therapy","volume":"15","author":"Haney","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.apsb.2026.01.013_bib145","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1021\/nn400269x","article-title":"Magnetic and photoresponsive theranosomes: translating cell-released vesicles into smart nanovectors for cancer therapy","volume":"7","author":"Silva","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib146","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib147","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s12276-023-01132-8","article-title":"Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications","volume":"56","author":"Jung","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304389","article-title":"Creating designer engineered extracellular vesicles for diverse ligand display, target recognition, and controlled protein loading and delivery","volume":"10","author":"Ivanova","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib149","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050442","article-title":"Extracellular vesicle- and extracellular vesicle mimetics-based drug delivery systems: new perspectives, challenges, and clinical developments","volume":"12","author":"Gangadaran","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2026.01.013_bib151","article-title":"Biomimetic exosomes: a new generation of drug delivery system","volume":"10","author":"Wang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib152","article-title":"Extracellular vesicle mimetics: preparation from top-down approaches and biological functions","volume":"11","author":"Du","year":"2022","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib153","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1039\/D0BM01676D","article-title":"Engineered drug-loaded cells and cell derivatives as a delivery platform for cancer immunotherapy","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib154","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.01.013_bib155","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41587-024-02504-9","article-title":"Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration","volume":"43","author":"Xie","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib156","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-202981","article-title":"Efficient generation of CAR-T by the first coacervate-based gene delivery system","volume":"144","author":"Zhu","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.01.013_bib157","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.apsb.2026.01.013_bib158","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.aba1624","article-title":"Synthetic cytokine circuits that drive T cells into immune-excluded tumors","volume":"378","author":"Allen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.01.013_bib159","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41422-023-00789-0","article-title":"Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness","volume":"33","author":"Chen","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.01.013_bib161","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/2326-6066.CIR-17-0502","article-title":"CAR-T cells surface-engineered with drug-encapsulated nanoparticles can ameliorate intratumoral T-cell hypofunction","volume":"6","author":"Siriwon","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib162","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41422-023-00828-w","article-title":"CAR T cell design: approaching the elusive and-gate","volume":"33","author":"Zhao","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib163","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2020.10.004","article-title":"Photoswitchable CAR-T cell function in vitro and in vivo via a cleavable mediator","volume":"28","author":"Zhang","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.apsb.2026.01.013_bib164","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib165","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.3390\/ijms22115899","article-title":"CAR-NK cells in the treatment of solid tumors","volume":"22","author":"Wrona","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib166","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","article-title":"CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy","volume":"14","author":"Chang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib167","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00262-024-03788-1","article-title":"Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy","volume":"73","author":"Duan","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.apsb.2026.01.013_bib168","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib169","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib170","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood.2024024523","article-title":"In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand","volume":"144","author":"Nicolai","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.01.013_bib171","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41587-022-01328-9","article-title":"In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice","volume":"40","author":"Nahmad","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib172","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers","volume":"12","author":"Smith","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib173","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.01.013_bib174","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn1128","article-title":"Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy","volume":"14","author":"Chen","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib175","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121424","article-title":"A CAR T-inspiring platform based on antibody-engineered exosomes from antigen-feeding dendritic cells for precise solid tumor therapy","volume":"282","author":"Fan","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.01.013_bib177","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1016\/j.cell.2023.10.001","article-title":"Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells","volume":"186","author":"Reincke","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.01.013_bib178","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1016\/j.cell.2022.10.026","article-title":"CAR T therapy extends its reach to autoimmune diseases","volume":"185","author":"Baker","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.01.013_bib179","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/CM9.0000000000003111","article-title":"Dawn of CAR-T cell therapy in autoimmune diseases","volume":"137","author":"Liu","year":"2024","journal-title":"Chin Med J (Engl Ed)"},{"key":"10.1016\/j.apsb.2026.01.013_bib180","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(20)31366-0","article-title":"Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study","volume":"396","author":"Abramson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.013_bib181","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib182","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(23)00023-5","article-title":"CD19-targeted CAR T cells in refractory antisynthetase syndrome","volume":"401","author":"Muller","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.01.013_bib183","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/biomedicines10020287","article-title":"CAR-T regulatory (CAR-Treg) cells: engineering and applications","volume":"10","author":"Arjomandnejad","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.01.013_bib184","doi-asserted-by":"crossref","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","article-title":"Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib185","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202404463","article-title":"Gene-engineered cerium-exosomes mediate atherosclerosis therapy through remodeling of the inflammatory microenvironment and DNA damage repair","volume":"20","author":"Wei","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.01.013_bib186","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1038\/s41467-022-30250-6","article-title":"Molecular insights into biogenesis of glycosylphosphatidylinositol anchor proteins","volume":"13","author":"Xu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213229","article-title":"Novel biomimetic mesoporous silica nanoparticle system possessing targetability and immune synergy facilitates effective solid tumor immuno-chemotherapy","volume":"144","author":"Zhu","year":"2023","journal-title":"Biomater Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib188","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s44222-024-00255-5","article-title":"The physico-chemical landscape of extracellular vesicles","volume":"3","author":"Manno","year":"2025","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.apsb.2026.01.013_bib189","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","article-title":"Therapeutically harnessing extracellular vesicles","volume":"21","author":"Cheng","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.01.013_bib190","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/s41467-019-12321-3","article-title":"CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity","volume":"10","author":"Fu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib191","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0092-8674(03)00112-0","article-title":"Membrane fusion","volume":"112","author":"Jahn","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.01.013_bib192","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41580-023-00668-x","article-title":"Mechanisms of SNARE proteins in membrane fusion","volume":"25","author":"Jahn","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.01.013_bib193","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.7150\/thno.45528","article-title":"Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2\/CCR2 signaling axis and promote drug delivery via SNARE-mediated membrane fusion","volume":"10","author":"Guo","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.01.013_bib194","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1083\/jcb.201901017","article-title":"How cells fuse","volume":"218","author":"Brukman","year":"2019","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2026.01.013_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120113","article-title":"Promotion of cell membrane fusion by cell\u2012cell attachment through cell surface modification with functional peptide-PEG-lipids","volume":"253","author":"Yoshihara","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.01.013_bib196","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm0597-558","article-title":"Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells","volume":"3","author":"Gong","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib197","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1101\/pdb.prot103176","article-title":"Polyethylene glycol fusion for hybridoma production","volume":"2018","author":"Greenfield","year":"2018","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.apsb.2026.01.013_bib198","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-021-03343-3","article-title":"Primate cell fusion disentangles gene regulatory divergence in neurodevelopment","volume":"592","author":"Agoglia","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.013_bib199","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.7150\/thno.16236","article-title":"Mouse IP-10 gene delivered by folate-modified chitosan nanoparticles and dendritic\/tumor cells fusion vaccine effectively inhibit the growth of hepatocellular carcinoma in mice","volume":"7","author":"Hu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.01.013_bib200","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1021\/acs.nanolett.2c00216","article-title":"Promoting cell fusion by polyvalent DNA ligands","volume":"22","author":"Gao","year":"2022","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2026.01.013_bib201","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1517\/17425247.2014.938632","article-title":"Cell electrofusion: past and future perspectives for antibody production and cancer cell vaccines","volume":"11","author":"Kanduser","year":"2014","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2026.01.013_bib202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nmeth.1290","article-title":"Microfluidic control of cell pairing and fusion","volume":"6","author":"Skelley","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.apsb.2026.01.013_bib203","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/nl5047494","article-title":"Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration","volume":"15","author":"Lee","year":"2015","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2026.01.013_bib204","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41565-022-01261-7","article-title":"Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics","volume":"18","author":"Shi","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib205","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202370103","article-title":"Membrane-fusion-mediated multiplex engineering of tumor cell surface glycans for enhanced NK cell therapy","volume":"35","author":"Zheng","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib206","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh2413","article-title":"Anti-phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy","volume":"9","author":"Zheng","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib207","article-title":"M2 macrophage hybrid membrane-camouflaged targeted biomimetic nanosomes to reprogram inflammatory microenvironment for enhanced enzyme-thermo-immunotherapy","volume":"35","author":"Chen","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib208","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.scib.2023.11.055","article-title":"In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesicles","volume":"69","author":"Zhao","year":"2024","journal-title":"Sci Bull"},{"key":"10.1016\/j.apsb.2026.01.013_bib209","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acsnano.7b00133","article-title":"Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy","volume":"11","author":"Rao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib210","article-title":"Dual-antigen-displaying nanovaccines elicit synergistic immunoactivation for treating cancer and preventing infectious complications","volume":"20","author":"Chen","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.01.013_bib211","article-title":"Expandable immunotherapeutic nanoplatforms engineered from cytomembranes of hybrid cells derived from cancer and dendritic cells","volume":"31","author":"Liu","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib212","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303835","article-title":"Extracellular vesicles-derived hybrid nanoplatforms for amplified CD47 blockade-based cancer immunotherapy","volume":"35","author":"Tang","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib213","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1038\/s41467-023-40788-8","article-title":"Cell type-specific delivery by modular envelope design","volume":"14","author":"Strebinger","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib214","first-page":"4028","article-title":"Multimodal engineering of extracellular vesicles for efficient intracellular protein delivery","volume":"16","author":"Liang","year":"2024","journal-title":"Bioengineering"},{"key":"10.1016\/j.apsb.2026.01.013_bib215","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1039\/D1NR04002B","article-title":"Neutrophil mediated postoperative photoimmunotherapy against melanoma skin cancer","volume":"13","author":"Wu","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2026.01.013_bib216","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210262","article-title":"Trojan horse nanocapsule enabled in situ modulation of the phenotypic conversion of Th17 cells to Treg cells for the treatment of multiple sclerosis in mice","volume":"35","author":"Shi","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib217","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305384","article-title":"Bacteria-based backpacks to enhance adoptive macrophage transfer against solid tumors","volume":"36","author":"An","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib218","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202315275","article-title":"Neutrophil hitchhiking biomimetic nanozymes prime neuroprotective effects of ischemic stroke in a tailored \u201cburning the bridges\u201d manner","volume":"34","author":"Song","year":"2024","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib219","doi-asserted-by":"crossref","first-page":"50499","DOI":"10.1021\/acsami.2c12218","article-title":"Cell-membrane-coated cationic nanoparticles disguised as macrophages for the prevention and treatment of type 2 diabetes mellitus","volume":"14","author":"Wu","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.01.013_bib220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12951-023-01773-x","article-title":"Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis","volume":"21","author":"Yang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib221","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1039\/D1BM00331C","article-title":"T cell membrane cloaking tumor microenvironment-responsive nanoparticles with a smart \u201cmembrane escape mechanism\u201d for enhanced immune-chemotherapy of melanoma","volume":"9","author":"Li","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib222","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/acsnano.2c09033","article-title":"Tumor-antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma","volume":"17","author":"Ma","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib223","article-title":"Biomimetic nanoparticles enabled by cascade cell membrane coating for direct cross-priming of T cells","volume":"18","author":"Chen","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.01.013_bib224","article-title":"NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions","volume":"13","author":"Luo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112365","article-title":"Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of abeta aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer's disease","volume":"129","author":"Huo","year":"2021","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.apsb.2026.01.013_bib226","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213373119","article-title":"Photoacoustic image-guided biomimetic nanoparticles targeting rheumatoid arthritis","volume":"119","author":"Chen","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.01.013_bib227","first-page":"1","article-title":"Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment","volume":"18","author":"Zhang","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib228","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1806444","article-title":"A combined \"eat me\/don't eat me\" strategy based on extracellular vesicles for anticancer nanomedicine","volume":"9","author":"Belhadj","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2026.01.013_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","volume":"103","author":"Tenspolde","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.apsb.2026.01.013_bib230","article-title":"First-in-world clinical trial of genetically engineered B cells: application to the treatment of mucopolysaccharidosis type I","volume":"31","author":"McIvor","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib231","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41563-023-01646-6","article-title":"In situ pegylation of CAR T cells alleviates cytokine release syndrome and neurotoxicity","volume":"22","author":"Gong","year":"2023","journal-title":"Nat Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib232","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through tcr-signaling-responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib233","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41565-021-00972-7","article-title":"T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy","volume":"16","author":"Zhai","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib234","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7150\/thno.40291","article-title":"Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.01.013_bib235","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202204822","article-title":"Biomimetic macrophage membrane and lipidated peptide hybrid nanovesicles for atherosclerosis therapy","volume":"32","author":"Guo","year":"2022","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.133848","article-title":"Biomimetic neutrophil and macrophage dual membrane-coated nanoplatform with orchestrated tumor-microenvironment responsive capability promotes therapeutic efficacy against glioma","volume":"433","author":"Yin","year":"2022","journal-title":"Chem Eng J"},{"key":"10.1016\/j.apsb.2026.01.013_bib237","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202405367","article-title":"Shape-versatile fixed cellular materials for multiple target immunomodulation","volume":"36","author":"Sousa","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib238","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI87624","article-title":"Biopolymers codelivering engineered T cells and sting agonists can eliminate heterogeneous tumors","volume":"127","author":"Smith","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.01.013_bib239","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae018","article-title":"Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor","volume":"11","author":"Liao","year":"2024","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.apsb.2026.01.013_bib240","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41587-022-01245-x","article-title":"Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells","volume":"40","author":"Agarwalla","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib241","article-title":"Designing hydrogels for immunomodulation in cancer therapy and regenerative medicine","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib242","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41551-021-00712-1","article-title":"Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets","volume":"5","author":"Hu","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.01.013_bib243","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12951-023-02119-3","article-title":"Bioinspired nanovesicles released from injectable hydrogels facilitate diabetic wound healing by regulating macrophage polarization and endothelial cell dysfunction","volume":"21","author":"Zhang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib244","article-title":"Living microneedle patch with adipose-derived stem cells embedding for diabetic ulcer healing","volume":"33","author":"Xu","year":"2022","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib245","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41551-021-00720-1","article-title":"Cryomicroneedles for transdermal cell delivery","volume":"5","author":"Chang","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.01.013_bib246","article-title":"Scattered seeding of CAR T cells in solid tumors augments anticancer efficacy","volume":"9","author":"Li","year":"2022","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.apsb.2026.01.013_bib247","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s44222-023-00141-6","article-title":"Microneedle biomedical devices","volume":"2","author":"Zheng","year":"2024","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.apsb.2026.01.013_bib248","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10544-023-00658-y","article-title":"Microneedles: materials, fabrication, and biomedical applications","volume":"25","author":"Luo","year":"2023","journal-title":"Biomed Microdevices"},{"key":"10.1016\/j.apsb.2026.01.013_bib249","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gendis.2021.09.006","article-title":"Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies","volume":"10","author":"Liu","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.apsb.2026.01.013_bib250","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"De Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2026.01.013_bib251","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201178","article-title":"Engineering CpG-ASO-Pt-loaded macrophages (CAP@M) for synergistic chemo-\/gene-\/immuno-therapy","volume":"11","author":"Wang","year":"2022","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib252","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1038\/s41467-018-07250-6","article-title":"MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma","volume":"9","author":"Wu","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.01.013_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115014","article-title":"Disease-specific suppressive granulocytes participate in glioma progression","volume":"43","author":"Zhao","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.01.013_bib254","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jconrel.2023.08.020","article-title":"Inflammatory responsive neutrophil-like membrane-based drug delivery system for post-surgical glioblastoma therapy","volume":"362","author":"Chen","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.01.013_bib255","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jconrel.2023.11.003","article-title":"Immune cell-derived exosomes as promising tools for cancer therapy","volume":"364","author":"Chen","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.01.013_bib256","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70068","article-title":"Dendritic cell derived-extracellular vesicles engineered to express interleukin-12 and anti-CTLA-4 on their surface for combinational cancer immunotherapy","volume":"14","author":"Chen","year":"2025","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2026.01.013_bib257","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib258","article-title":"Live macrophages loaded with Fe3O4 and sulfasalazine for ferroptosis and photothermal therapy of rheumatoid arthritis","volume":"24","author":"Ruan","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.apsb.2026.01.013_bib259","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.apsb.2023.09.013","article-title":"GRK2 inhibits Flt-1+ macrophage infiltration and its proangiogenic properties in rheumatoid arthritis","volume":"14","author":"Yang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.01.013_bib260","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM200103223441207","article-title":"Cytokine pathways and joint inflammation in rheumatoid arthritis","volume":"344","author":"Choy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2024.213764","article-title":"Neutrophils-mediated bioinspired nanoagents for noninvasive monitoring of inflammatory recruitment dynamics and navigating phototherapy in rheumatoid arthritis","volume":"158","author":"Yu","year":"2024","journal-title":"Biomater Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib262","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1016\/S2665-9913(21)00061-8","article-title":"Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial","volume":"3","author":"Pratt","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.apsb.2026.01.013_bib263","doi-asserted-by":"crossref","first-page":"13917","DOI":"10.1021\/acsnano.3c03828","article-title":"A dual-targeted metal-organic framework based nanoplatform for the treatment of rheumatoid arthritis by restoring the macrophage niche","volume":"17","author":"Tao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib264","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867260","article-title":"The role of M1\/M2 macrophage polarization in rheumatoid arthritis synovitis","volume":"13","author":"Cutolo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102068","article-title":"Macrophage-hitchhiking interleukin-10 plasmid DNA delivery system modulates rheumatoid arthritis microenvironment via the re-polarization of macrophages","volume":"54","author":"Zhang","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2026.01.013_bib266","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1091","article-title":"Cell-based therapies for the treatment of rheumatoid arthritis","volume":"11","author":"Moghaddam","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.apsb.2026.01.013_bib267","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/art.41812","article-title":"Is there a place for chimeric antigen receptor-T cells in the treatment of chronic autoimmune rheumatic diseases?.","volume":"73","author":"Orvain","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.apsb.2026.01.013_bib268","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/art.42081","article-title":"Safety and efficacy of mesenchymal stromal cells and other cellular therapeutics in rheumatic diseases in 2022: a review of what we know so far","volume":"74","author":"Gilkeson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.apsb.2026.01.013_bib269","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/ard-2022-223645","article-title":"Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance","volume":"82","author":"Yamada","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.apsb.2026.01.013_bib270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161148","article-title":"The role of dendritic cells and their immunometabolism in rheumatoid arthritis","volume":"14","author":"Suwa","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib271","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41419-022-04695-y","article-title":"Dopamine D3 receptor signaling alleviates mouse rheumatoid arthritis by promoting toll-like receptor 4 degradation in mast cells","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.01.013_bib272","doi-asserted-by":"crossref","first-page":"26525","DOI":"10.1021\/acsnano.5c04787","article-title":"Dual-pronged attack: biomimetic multi-functional mofs for rheumatoid arthritis therapy via inhibiting synovial hyperplasia and improving immune microenvironment","volume":"19","author":"Ma","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib273","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202302503","article-title":"A targeted exosome therapeutic confers both cfDNA scavenging and macrophage polarization for ameliorating rheumatoid arthritis","volume":"35","author":"Wang","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib274","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41392-021-00805-y","article-title":"Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib275","first-page":"337","article-title":"Engineered macrophage-biomimetic versatile nanoantidotes for inflammation-targeted therapy against Alzheimer's disease by neurotoxin neutralization and immune recognition suppression","volume":"26","author":"Cheng","year":"2023","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib276","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/intimm\/dxs049","article-title":"Inflammation and type one diabetes","volume":"24","author":"Bending","year":"2012","journal-title":"Int Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib277","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.abh1654","article-title":"Immunotherapy: building a bridge to a cure for type 1 diabetes","volume":"373","author":"Bluestone","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.01.013_bib278","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/antiox11050953","article-title":"Type 2 diabetes and oxidative stress and inflammation: pathophysiological mechanisms and possible therapeutic options","volume":"11","author":"Vassalle","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.apsb.2026.01.013_bib279","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.01.013_bib280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930553","article-title":"The contribution of neutrophils and nets to the development of type 1 diabetes","volume":"13","author":"Petrelli","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib281","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036245","article-title":"Type 1 diabetes mellitus: roles of neutrophils in the pathogenesis","volume":"102","author":"Obeagu","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.apsb.2026.01.013_bib282","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027071","article-title":"Platelet-neutrophil interaction and thromboinflammation in diabetes: considerations for novel therapeutic approaches","volume":"11","author":"Gauer","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.apsb.2026.01.013_bib283","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.3390\/ijms23094885","article-title":"Dendritic cells and their immunotherapeutic potential for treating type 1 diabetes","volume":"23","author":"Khan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib284","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/cells10081875","article-title":"Mast cells and the pancreas in human type 1 and type 2 diabetes","volume":"10","author":"Masini","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.01.013_bib285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1142648","article-title":"Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8+ T cells","volume":"14","author":"Peters","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.01.013_bib286","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2016.12.007","article-title":"Adoptive transfer of mRNA-transfected T cells redirected against diabetogenic CD8 T cells can prevent diabetes","volume":"25","author":"Fishman","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib287","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3484","article-title":"Application of CAR-T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment","volume":"25","author":"Adabi","year":"2023","journal-title":"J Gene Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib288","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/DMSO.S345890","article-title":"Which bmi for diabetes patients is better? From the view of the adipose tissue macrophage-derived exosome","volume":"15","author":"Liu","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.apsb.2026.01.013_bib289","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2022.04.002","article-title":"The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment","volume":"66","author":"Gao","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.apsb.2026.01.013_bib290","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?.","volume":"19","author":"Engelen","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.apsb.2026.01.013_bib291","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/CIRCRESAHA.120.315942","article-title":"Vaccination strategies and immune modulation of atherosclerosis","volume":"126","author":"Nilsson","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.01.013_bib292","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/eurheartj\/ehad304","article-title":"Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond","volume":"44","author":"Weber","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.01.013_bib293","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10565-022-09732-2","article-title":"MiR-199a-5p-containing macrophage-derived extracellular vesicles inhibit SMARCA4 and alleviate atherosclerosis by reducing endothelial cell pyroptosis","volume":"39","author":"Liang","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.apsb.2026.01.013_bib294","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/cells12040522","article-title":"The role of macrophages in the pathogenesis of atherosclerosis","volume":"12","author":"Blagov","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.01.013_bib295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.013_bib296","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202315034","article-title":"A zombie macrophage-based \u201ctrojan horse\u201d enhances the effect of efferocytosis through immune regulation for atherosclerosis treatment","volume":"34","author":"Yao","year":"2024","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib297","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122505","article-title":"Biomimetic nanodrug targets inflammation and suppresses yap\/taz to ameliorate atherosclerosis","volume":"306","author":"Huang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.01.013_bib298","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12951-022-01720-2","article-title":"Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect","volume":"20","author":"Sha","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.01.013_bib299","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41419-023-06206-z","article-title":"Macrophage polarization and metabolism in atherosclerosis","volume":"14","author":"Hou","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.01.013_bib300","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41586-024-07693-6","article-title":"Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming","volume":"634","author":"Lavillegrand","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.01.013_bib301","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1021\/acsnano.3c00288","article-title":"Neutrophil-membrane-coated biomineralized metal-organic framework nanoparticles for atherosclerosis treatment by targeting gene silencing","volume":"17","author":"Liu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib302","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ymthe.2024.11.034","article-title":"Engineered extracellular vesicles as nanosponges for lysosomal degradation of pcsk9","volume":"33","author":"Wang","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib303","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s00018-018-2844-6","article-title":"The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease","volume":"75","author":"Salminen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib304","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/alz.13490","article-title":"Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: evidence from clinical and preclinical studies","volume":"20","author":"Gaikwad","year":"2024","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.apsb.2026.01.013_bib305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114161","article-title":"Exosomes: a missing link between chronic systemic inflammation and Alzheimer's disease?.","volume":"159","author":"Ozansoy","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.01.013_bib306","article-title":"Chimeric antigen receptor macrophages target and resorb amyloid plaques in a mouse model of Alzheimer's disease","author":"Pan","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2026.01.013_bib307","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3390\/cells12162115","article-title":"Development of beta-amyloid-specific CAR-Tregs for the treatment of Alzheimer's disease","volume":"12","author":"Saetzler","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.01.013_bib308","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fncel.2019.00355","article-title":"Innate immune cells: monocytes, monocyte-derived macrophages and microglia as therapeutic targets for Alzheimer's disease and multiple sclerosis","volume":"13","author":"Fani","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2026.01.013_bib309","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj0624","article-title":"Genome-editing prodrug: targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease","volume":"7","author":"Yan","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib310","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101526","article-title":"Macrophage-disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib311","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1021\/acs.nanolett.2c02560","article-title":"Macrophage-membrane-camouflaged nonviral gene vectors for the treatment of multidrug-resistant bacterial sepsis","volume":"22","author":"Cao","year":"2022","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2026.01.013_bib312","first-page":"531","article-title":"Cytokine nanosponges suppressing overactive macrophages and dampening systematic cytokine storm for the treatment of hemophagocytic lymphohistiocytosis","volume":"21","author":"Wang","year":"2023","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib313","article-title":"Nanoparticle-enhanced mesalazine therapy for inflammatory bowel disease","volume":"1","author":"Sutaria","year":"2023","journal-title":"Pharma Sci Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib314","article-title":"IL23R-specific CAR Tregs for the treatment of Crohn's disease","volume":"19","author":"Cui","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.apsb.2026.01.013_bib315","article-title":"Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis","volume":"20","author":"Wang","year":"2023","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.apsb.2026.01.013_bib316","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado6798","article-title":"Oral microsphere formulation of M2 macrophage-mimetic janus nanomotor for targeted therapy of ulcerative colitis","volume":"10","author":"Luo","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib317","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nmat4644","article-title":"Biomimetic proteolipid vesicles for targeting inflamed tissues","volume":"15","author":"Molinaro","year":"2016","journal-title":"Nat Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib318","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304023","article-title":"Orally-delivered, cytokine-engineered extracellular vesicles for targeted treatment of inflammatory bowel disease","volume":"19","author":"Liu","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.01.013_bib319","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","article-title":"Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.01.013_bib320","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1517\/14656566.2012.685163","article-title":"Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy","volume":"13","author":"Sharma","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.apsb.2026.01.013_bib321","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.7150\/thno.19979","article-title":"Direct macromolecular drug delivery to cerebral ischemia area using neutrophil-mediated nanoparticles","volume":"7","author":"Zhang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.01.013_bib322","article-title":"M2 macrophage-derived exosomes inhibiting neutrophil extracellular traps for ischemic stroke therapy","volume":"34","author":"Wang","year":"2024","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.01.013_bib323","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12264-025-01376-6","article-title":"Engineered extracellular vesicles loaded with miR-100-5p antagonist selectively target the lesioned region to promote recovery from brain damage","volume":"41","author":"Cheng","year":"2025","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.apsb.2026.01.013_bib324","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"Van der Poll","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.01.013_bib325","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscia.2025.100087","article-title":"Nanoplatforms in sepsis storm: multimodal synergy for precision immunomodulation and pathogen neutralizations","volume":"3","author":"Wang","year":"2025","journal-title":"Pharmaceutical Science Advances"},{"key":"10.1016\/j.apsb.2026.01.013_bib326","article-title":"Lipid droplet-enriched luminogens enable adoptive macrophage transfer for treatment of bacterial sepsis","volume":"11","author":"Liu","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.01.013_bib327","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/acsnano.3c10109","article-title":"mRNA-laden lipid-nanoparticle-enabled in situ CAR-macrophage engineering for the eradication of multidrug-resistant bacteria in a sepsis mouse model","volume":"18","author":"Tang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib328","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1021\/acsnano.4c12917","article-title":"Framework nucleic acid-based and neutrophil-based nanoplatform loading baicalin with targeted drug delivery for anti-inflammation treatment","volume":"19","author":"Zhou","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib329","doi-asserted-by":"crossref","first-page":"28228","DOI":"10.1021\/acsnano.4c08157","article-title":"Biomimetic nanomodulator regulates oxidative and inflammatory stresses to treat sepsis-associated encephalopathy","volume":"18","author":"Qu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib330","article-title":"Engineered extracellular vesicles driven by erythrocytes ameliorate bacterial sepsis by iron recycling, toxin clearing and inflammation regulation","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2026.01.013_bib331","doi-asserted-by":"crossref","first-page":"16726","DOI":"10.1021\/acsnano.4c01780","article-title":"Carbon dot-loaded apoptotic vesicles improve the liver kupffer cell-mediated antibacterial effect to synergistically alleviate sepsis","volume":"18","author":"Xiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.01.013_bib332","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-024-01621-x","article-title":"Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms","volume":"17","author":"Wu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.01.013_bib333","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.01.013_bib334","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/CMAR.S521944","article-title":"Novel loop-structure-based CD19\/CD22 dual-target CAR-T therapy for high-risk diffuse large B-cell lymphoma presenting with hemophagocytic lymphohistiocytosis: a case report","volume":"17","author":"Ye","year":"2025","journal-title":"Cancer Manag Res"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:44:01Z","timestamp":1779414241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":334,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2211383526000316"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.01.013","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in immune cell-based therapeutic agents for the treatment of inflammation-related diseases","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}